The Transition From Phase II To Phase III Studies

被引：8

作者：

Berthold, Dominik R. ^{[1
,2
,3
]}

Gulamhusein, Aliya ^{[1
,2
,4
]}

Jackson, John I. ^{[1
,2
]}

Tannock, Ian F. ^{[1
,2
]}

机构：

[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[2] Univ Toronto, Toronto, ON, Canada

[3] Oncol Inst So Switzerland, Bellinzona, Switzerland

[4] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 07期

关键词：

D O I：

10.1200/JCO.2008.21.1938

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1150 / 1151

页数：3

共 4 条

[1]

THE FATE OF ABSTRACTS SUBMITTED TO A CANCER MEETING - FACTORS WHICH INFLUENCE PRESENTATION AND SUBSEQUENT PUBLICATION [J].

DEBELLEFEUILLE, C ;

MORRISON, CA ;

TANNOCK, IF .

ANNALS OF ONCOLOGY, 1992, 3 (03) :187-191

[2]

Economics of new oncology drug development [J].

DiMasi, Joseph A. ;

Grabowski, Henry G. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (02) :209-216

[3]

The costs of conducting clinical research [J].

Emanuel, EJ ;

Schnipper, LE ;

Kamin, DY ;

Levinson, J ;

Lichter, AS .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4145-4150

[4]

Trends in clinical trials reports in common cancers between 1989 and 2000 [J].

Hillner, BE .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1850-1858

← 1 →